Live Poll Results — Which pharmaceutical product innovation first successfully extended the dosing i
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Innovation Breakthrough
The medical industry is constantly evolving with groundbreaking product innovations. One particular innovation revolutionized how patients manage chronic conditions by dramatically reducing administration frequency. This product innovation transformed the standard of care for millions of patients worldwide and represented a significant leap in medical technology. Test your knowledge about this game-changing pharmaceutical advancement that changed treatment paradigms.
Which pharmaceutical product innovation first successfully extended the dosing interval from daily to weekly or monthly for chronic disease management, creating a new standard for patient convenience?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Exenatide LAR (Bydureon) - First once-weekly GLP-1 receptor agonist for type 2 diabetes', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Risperdal Consta - First atypical antipsychotic available as a long-acting injectable', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Forteo - First anabolic agent for osteoporosis requiring daily self-injection', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Rebif - First interferon beta-1a therapy for multiple sclerosis with titratable dosing', 'is_correct': False} | 0 | 0% |